Chauhan G, Rieder F
Surg Clin North Am. 2025; 105(2):201-215.
PMID: 40015812
PMC: 11868724.
DOI: 10.1016/j.suc.2024.10.008.
Kawtharani A, Akiki L, Rachid A, Geagea A, Abi Abboud A
Cureus. 2025; 17(1):e77400.
PMID: 39949431
PMC: 11822214.
DOI: 10.7759/cureus.77400.
Brizzi A, Rispoli R, Autore G, Marzocco S
Int J Mol Sci. 2025; 26(3).
PMID: 39940655
PMC: 11817955.
DOI: 10.3390/ijms26030885.
Bosco V, Mercuri C, Doldo P, Nocerino R, Guillari A, Virgolesi M
Nurs Health Sci. 2025; 27(1):e70058.
PMID: 39928987
PMC: 11810439.
DOI: 10.1111/nhs.70058.
Yu X, Cao Y, Mao C, Tao C, Chen W
Biochem Genet. 2025; .
PMID: 39913044
DOI: 10.1007/s10528-025-11037-y.
Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History.
Brunet-Mas E, Selva A, Bas-Cutrina F, Brujats A, Caballol B, Font R
Clin Transl Gastroenterol. 2024; 16(2):e00740.
PMID: 39729123
PMC: 11845185.
DOI: 10.14309/ctg.0000000000000740.
The effect of workplace environment on coal miners' gut microbiota in a mouse model.
Li L, Zhi M, Wang S, Deng J, Cai Q, Feng D
Front Microbiol. 2024; 15:1453798.
PMID: 39723143
PMC: 11668784.
DOI: 10.3389/fmicb.2024.1453798.
The N-Acetyltransferase 2 Polymorphism and Susceptibility to Inflammatory Bowel Disease: A Case-Control Study.
Petryszyn P, Zurakowski G, Dudkowiak R, Machowska M, Gruca A, Ekk-Cierniakowski P
Pharmacol Res Perspect. 2024; 13(1):e70040.
PMID: 39720855
PMC: 11669041.
DOI: 10.1002/prp2.70040.
Predictive value of three nutritional indexes for disease activity in patients with inflammatory bowel disease.
Chen Z, Zeng L, Cai W, Song X, Xu Q, Xu J
Ann Med. 2024; 57(1):2443256.
PMID: 39705015
PMC: 11703468.
DOI: 10.1080/07853890.2024.2443256.
Synergistic Benefits of Dietary Strategies in the Management of IBD.
Dryden G, Dryden S
Curr Gastroenterol Rep. 2024; 27(1):8.
PMID: 39702516
DOI: 10.1007/s11894-024-00949-1.
Amelioration of inflammatory bowel disease by subsp. XLTG11 in combination with mesalazine.
Ma W, Wu Y, Lin X, Yang L, Huang L
Front Microbiol. 2024; 15:1472776.
PMID: 39697653
PMC: 11652597.
DOI: 10.3389/fmicb.2024.1472776.
Trajectories of adherence to intravenous biological treatment in patients with inflammatory bowel disease: a longitudinal analysis.
Dong X, Zhu S, Jin Y, Ren C, Chen C
Front Pharmacol. 2024; 15:1431035.
PMID: 39669202
PMC: 11634588.
DOI: 10.3389/fphar.2024.1431035.
Raising the bar in ulcerative colitis management.
Fanizzi F, Allocca M, Fiorino G, Zilli A, Furfaro F, Parigi T
Therap Adv Gastroenterol. 2024; 17:17562848241273066.
PMID: 39600566
PMC: 11589388.
DOI: 10.1177/17562848241273066.
Sex-related differences in profiles and clinical outcomes of Inflammatory bowel disease: a systematic review and meta-analysis.
Salem D, El-Ijla R, AbuMusameh R, Zakout K, Abu Halima A, Abudiab M
BMC Gastroenterol. 2024; 24(1):425.
PMID: 39580396
PMC: 11585250.
DOI: 10.1186/s12876-024-03514-2.
Inflammatory bowel disease: a narrative review of disease evolution in South Asia and India over the last decade.
Shankar S, Majumder S, Mukherjee S, Bhaduri A, Kasturi R, Ghosh S
Therap Adv Gastroenterol. 2024; 17:17562848241258360.
PMID: 39575157
PMC: 11580062.
DOI: 10.1177/17562848241258360.
Maternal diet in pregnancy and the risk of inflammatory bowel disease in the offspring: a prospective cohort study.
Guo A, Brantsaeter A, Borge T, Af Segerstad E, Imberg H, Marild K
Am J Clin Nutr. 2024; 121(1):32-39.
PMID: 39461723
PMC: 11747187.
DOI: 10.1016/j.ajcnut.2024.10.017.
Therapeutic and Immunologic Effects of Short-Chain Fatty Acids in Inflammatory Bowel Disease: A Systematic Review.
Ventura I, Chomon-Garcia M, Tomas-Aguirre F, Palau-Ferre A, Legidos-Garcia M, Murillo-Llorente M
Int J Mol Sci. 2024; 25(20).
PMID: 39456661
PMC: 11506931.
DOI: 10.3390/ijms252010879.
Neutrophil-fibroblast crosstalk drives immunofibrosis in Crohn's disease through IFNα pathway.
Gavriilidis E, Divolis G, Natsi A, Kafalis N, Kogias D, Antoniadou C
Front Immunol. 2024; 15:1447608.
PMID: 39346917
PMC: 11427415.
DOI: 10.3389/fimmu.2024.1447608.
NLRP3 Inflammasome and Gut Dysbiosis Linking Diabetes Mellitus and Inflammatory Bowel Disease.
Malicevic U, Rai V, Skrbic R, Agrawal D
Arch Intern Med Res. 2024; 7(3):200-218.
PMID: 39328924
PMC: 11426418.
DOI: 10.26502/aimr.0178.
Bioelectronic Medicines-A Novel Approach of Therapeutics in Current Epoch.
Kumar A, Ashawat M, Pandit V, Kumar P
Curr Pharm Des. 2024; 31(3):163-178.
PMID: 39313906
DOI: 10.2174/0113816128326489240827100537.